The MALDI Biotyper from Bruker
As a result of the global SARS-CoV-2pandemic, clinical microbiology laboratories are facing a significantly increased workload. On top of testing for the virus, those critically ill with COVID-19 are susceptible to secondary bacterial infections.
Bruker’s MALDI Biotyper can be implemented with the MBT Sepsityper IVD Kit, enabling reliable species identification directly from positive blood cultures in 15–20 minutes.
“The Sepsityper solution has revolutionised diagnostic microbiology in our laboratory. With rapid identification of a blood culture flagging positive, we are able to change treatment and management properly, escalating or de-escalating as appropriate. Reducing the time to identification means we are able to improve patient outcomes dramatically, and the Sepsityper has not only improved clinical outcomes but diagnostic practice as well,” says Francis Yongblah, Laboratory Manager and HSST Clinical Scientist.
www.bruker.com
Other News
Featured Supplier
Often, better healthcare is less about pioneering breakthroughs or techniques and more about finding ways to better use existing technology to improve outcomes. And that’s what Una Health is all about: taking an innovative approach to diagnostics to challenge traditional pathways and improve patient outcomes.
We specialise in Pathology and...
Upcoming Events
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
